conducted a population-based cohort study to assess the risk of various cancers, including those of the lung, thyroid, skin, and liver, among patients treated with amiodarone, and revealed a borderline significant (standardized incidence ratios, 1.12; 95% CI, 0.99–1.26) increased risk associated with the use of this drug [ 12 ].
← all excerpts
Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.
1
—
—